Berkeley, CA · Founded 2021 · Privately Held (backing)
Developer of optogenetic gene therapies designed for vision restoration purposes. Ray Therapeutics is based in Berkeley, CA and was founded in 2021. It has raised $106 million across 2 recorded rounds; the latest was a $14 million early-stage round in May 2023.
Last price · $/share
—
Implied valuation
—
Total raised
$106.0M
Last round
Early Stage VC
May 2023
Team — not yet on record
No current team members for Ray Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ray Therapeutics with a free account
·Watch Ray Therapeutics: the Monday email on marks, rounds and moves
